Portfolio tracker
You will need to register with Boston.com before you can create a new portfolio, get stock and mutual fund alerts, and more.
Investment tools
- stocks
-
- Most active
- |
- Gainers
- |
- Losers
- manage
-
- Stocks
- |
- Commodities
- |
- Funds
Charles River rises as earnings beat estimates
Charles River Laboratories International Inc., the seller of mice and rats used in laboratory experiments, gained the most in a month after reporting earnings that beat analyst estimates. Charles River climbed 3.9 percent to $35.23 at 4 p.m. in New York, the biggest increase since Jan. 10. The Wilmington, Massachusetts-based company reported earnings excluding one-time items of 69 cents a share, beating by 10 cents the average of 16 analyst estimates compiled by Bloomberg.
More headlines
- Aveo takes bigger 4Q loss on drug development
- US stocks pare losses on optimism Greece to commit to EU plan
- Arbitron climbs as forecast tops estimates
- Greek vote helps lift the price of oil
- BOSTON CAPITAL Brightcove braces for tough IPO market
- Complete Genomics
Economic data
Most active
Gainers
Losers